Case number 1:20-cv-00632
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 20, 2021 | 34 | Stipulation and Order of Dismissal (2) |
| Oct 20, 2021 | 34 | Main Document (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See Attached. (Attachments: # (1) Stipulation and Order of Dismissal)(kmd) |
| Oct 20, 2021 | 33 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER (Case Closed). Signed by Judge Colm F. Connolly on 10/20/2021. (kmd) |
| Oct 20, 2021 | 32 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal and [Proposed Order] as to all Defendants with Prejudice by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jul 26, 2021 | 31 | SO ORDERED (5) Docket Text: SO ORDERED, re [30] Stipulation filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Case stayed. Signed by Judge Colm F. Connolly on 7/26/2021. (fms) |
| Jul 23, 2021 | 30 | Stipulation (5) Docket Text: STIPULATION and Order of Stay Pending Appeal by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 14, 2021 | 29 | SO ORDERED (2) Docket Text: SO ORDERED, re [28] STIPULATION TO EXTEND TIME for Defendants' to Serve Invalidity Contentions to July 26, 2021 filed by Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd., Aurobindo Pharma, Ltd.. Signed by Judge Colm F. Connolly on 6/14/2021. (fms) |
| Jun 10, 2021 | 28 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants' to Serve Invalidity Contentions to July 26, 2021 - filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialities Ltd.. (Dorsney, Kenneth) |
| Mar 12, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 11, 2020 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) (2) Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery (3) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) (4) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 11, 2020 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants Aurobindo USA, Inc., Aurobindo Pharma, Ltd., and Eugia Pharma Specialties, Ltd.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendants Aurobindo USA, Inc., Aurobindo Pharma, Ltd., and Eugia Pharma Specialties, Ltd.'s Paragraph 3 Disclosures filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialities Ltd..(Dorsney, Kenneth) |
| Dec 8, 2020 | 24 | Protective Order (24) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 12/8/2020. (fms) |
| Dec 7, 2020 | 23 | Proposed Order (24) Docket Text: PROPOSED ORDER (Protective Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 19, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Marc N. Zubick, Kenneth G. Schuler, Alex M. Grabowski for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 18, 2020 | 22 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Kenneth G. Schuler and Alex Grabowski - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Nov 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Kenneth G. Schuler and Alex Grabowski filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 11/18/2020. (nmf) |
| Nov 17, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David I. Berl,Adam D. Harber and Ben V. Picozzi for Cephalon, Inc. and Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Nov 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 12/8/20 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 11/17/20. (cak) |
| Nov 17, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Nov 13, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Courts website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in the manner set forth in the Scheduling Order. ORDERED by Judge Jennifer L. Hall on 11/13/2020. (ceg) |
| Nov 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney David L. Berl, Adam D. Harber and Ben V. Picozzi filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 11/12/2020. (fms) |
| Nov 12, 2020 | 19 | Scheduling Order (23) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes related to discovery and the protective order. Joinder of Parties due by 11/5/2021. Amended Pleadings due by 11/5/2021. Fact Discovery completed by 11/5/2021. Proposed Pretrial Order due by 6/8/2022. A Final Pretrial Conference is set for 6/29/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 7/18/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 11/12/2020. (nmf) |
| Nov 10, 2020 | 18 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding Joint Proposed Scheduling Order. (Attachments: # (1) Joint Proposed Scheduling Order)(Hoeschen, Nathan) |
| Nov 10, 2020 | 18 | Joint Proposed Scheduling Order (23) |
| Nov 10, 2020 | N/A | Remark (0) Docket Text: The 11/12/2020 Scheduling Conference is canceled as there are no areas of disagreement in the proposed order. (nmf) |
| Nov 10, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David L. Berl, Adam D. Harber and Ben V. Picozzi - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 22, 2020 | 16 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 11/12/2020 at 03:30 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 10/21/2020. (nmf) |
| Aug 10, 2020 | 15 | Answer to Counterclaim (15) Docket Text: ANSWER to [13] Answer to Complaint,, Counterclaim, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jul 20, 2020 | 13 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, , COUNTERCLAIM against Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH by Aurobindo Pharma, Ltd., Eugia Pharma Specialities Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jul 20, 2020 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma, Ltd. for Aurobindo Pharma USA, Inc., Eugia Pharma Specialities Ltd. filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialities Ltd.. (Dorsney, Kenneth) |
| Jun 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] Proposed Order filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Aurobindo Pharma USA, Inc. answer due 7/20/2020. Signed by Judge Colm F. Connolly on 6/2/2020. (fms) |
| Jun 2, 2020 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.: For Aurobindo Pharma, Ltd. waiver sent on 5/18/2020, answer due 8/17/2020. (Hoeschen, Nathan) |
| Jun 2, 2020 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.: For Eugia Pharma Specialities Ltd. waiver sent on 5/18/2020, answer due 8/17/2020. (Hoeschen, Nathan) |
| Jun 2, 2020 | 12 | Proposed Order (1) Docket Text: PROPOSED ORDER (Notice of Extension of Time to Respond to the complaint) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 13, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| May 13, 2020 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. Aurobindo Pharma USA, Inc. served on 5/12/2020, answer due 6/2/2020. (Hoeschen, Nathan) |
| May 11, 2020 | 1 | Main Document (66) Docket Text: COMPLAINT filed against Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialities Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2925778.) - filed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Civil Cover Sheet)(mal) |
| May 11, 2020 | 8 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| May 11, 2020 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc., Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc.. (mal) |
| May 11, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc. Teva Pharmaceutical Industries Ltd. is the only publicly traded company that owns 10% or more of the stock of Cephalon, Inc. filed by Cephalon, Inc.. (mal) |
| May 11, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals International GmbH. Teva Pharmaceutical Industries Ltd. is the only publicly traded company that owns 10% or more of the stock of Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (mal) |
| May 11, 2020 | 4 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) see attached list. (mal) |
| May 11, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 6, 2020. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: October 6, 2022. (mal) |
| May 11, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| May 11, 2020 | 1 | Civil Cover Sheet (1) |
| May 11, 2020 | 1 | Exhibit N (13) |
| May 11, 2020 | 1 | Exhibit M (12) |
| May 11, 2020 | 1 | Exhibit L (9) |
| May 11, 2020 | 1 | Exhibit K (7) |
| May 11, 2020 | 1 | Exhibit J (13) |
| May 11, 2020 | 1 | Exhibit I (13) |
| May 11, 2020 | 1 | Exhibit H (13) |
| May 11, 2020 | 1 | Exhibit G (18) |
| May 11, 2020 | 1 | Exhibit F (12) |
| May 11, 2020 | 1 | Exhibit E (13) |
| May 11, 2020 | 1 | Exhibit D (10) |
| May 11, 2020 | 1 | Exhibit C (10) |
| May 11, 2020 | 1 | Exhibit B (9) |
| May 11, 2020 | 1 | Exhibit A (11) |
| May 11, 2020 | 1 | Complaint* (1) |
